Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Kidney Transplant Recipients
100%
Toxicity Management
50%
Tacrolimus Toxicity
50%
Cell Therapy
50%
Regulatory T Cells
50%
Kidney Transplant
50%
Treg
50%
Thrombotic Microangiopathy
50%
Glomerulonephritis
50%
Tacrolimus
50%
Infective Endocarditis
50%
Multicenter Retrospective Cohort Study
50%
Clinical Impact
50%
Clinical Progress
50%
Chimeric Antigen Receptor T-cell Therapy
50%
Systemic Lupus Erythematosus
50%
Metastatic Renal Cell Carcinoma (mRCC)
50%
Reduced Toxicity
50%
Angiotensin Receptor Blockers
50%
Angiotensin-converting Enzyme Inhibitor (ACEi)
50%
Tyrosine Kinase Inhibitor
50%
Cell-free DNA (cfDNA)
50%
Clinical Parameters
50%
Kidney Transplantation
39%
Autoimmune Disease
37%
Tacrolimus Level
33%
Immunosuppression
25%
Advanced Renal Cell Carcinoma
25%
Proteinuria
25%
Graft Rejection
23%
Immunosuppressive Therapy
22%
Immune Tolerance
20%
Enzyme Inducer
16%
Risk of Rejection
16%
Subtherapeutic Concentrations
16%
Chimeric Antigen Receptor T Cells (CAR-T)
16%
Dose Interruption
14%
Graft Failure
13%
Clinical Outcomes
12%
Thymus
12%
Cell-based
12%
Immune Cells
12%
Tumor Microenvironment
12%
Life-threatening Infections
12%
Allograft Rejection
12%
Immunosuppressive Drugs
12%
Malignancy
12%
Contact-dependent
12%
Immune Response
12%
Patient Outcomes
12%
Medicine and Dentistry
Kidney Graft
100%
Immunosuppressive Treatment
68%
Kidney Transplantation
60%
Immunosuppressive Drug
50%
Immunocompetent Cell
50%
Regulatory T Cell
50%
Cell Therapy
50%
Infective Endocarditis
50%
Glomerulonephritis
50%
Autoimmune Disease
50%
Systemic Lupus Erythematosus
50%
Chimeric Antigen Receptor T-Cell Immunotherapy
50%
Retrospective Study
50%
Kidney Metastasis
50%
Tyrosine-Kinase Inhibitor
50%
Angiotensin Receptor Antagonist
50%
ACE Inhibitor
50%
Cell-Free DNA
50%
Immunological Tolerance
41%
Immunotherapy
28%
Clear Cell Renal Cell Carcinoma
28%
Graft Rejection
25%
Infection
25%
Immune Response
25%
Tumor Microenvironment
25%
Cancer
25%
Thymus
25%
B Cell
25%
Proteinuria
25%
Chimeric Antigen Receptor T-Cell
16%
Case Presentation
10%
Neutrophil Cytoplasmic Antibody
10%
Clinical Finding
10%
Biological Marker
10%
Hyaline Degeneration
10%
Kidney Function
10%
Biopsy Technique
10%
B Cell Maturation Antigen
8%
T Cell
8%
Cell Antigen
8%
Immunosuppressant
8%
Cost-Effectiveness Analysis
8%
Immune Complex Deposition
8%
Spontaneous Remission
8%
Oncology
8%
Pharmacology, Toxicology and Pharmaceutical Science
Tacrolimus
100%
Cohort Study
50%
HIV
50%
Thrombotic Thrombocytopenic Purpura
50%
Retrospective Study
50%
Kidney Metastasis
50%
Angiotensin Receptor Antagonist
50%
Dipeptidyl Carboxypeptidase Inhibitor
50%
Protein Tyrosine Kinase Inhibitor
50%
Renal Cell Carcinoma
28%
Immunosuppressive Agent
27%
Proteinuria
25%
Rifampicin
14%
Graft Rejection
13%
Graft Failure
13%
Mycophenolate Mofetil
7%
Human Immunodeficiency Virus Infection
7%
Drug-Drug Interaction
7%
Isoniazid
7%
Cytochrome P450 Inducer
7%
Enzyme Induction
7%
